Diagnostic Evidence Co-operative Newcastle
The Diagnostic Evidence Co-operative Newcastle is a partnership between Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University.
The NIHR DEC Newcastle facilitates the generation of high quality evidence on clinical validity, utility and cost-effectiveness of in vitro diagnostic medical devices (IVDs) for use in the NHS.
For more information see About us
News & Developments
Industrial Strategy Challenge Fund (ISCF)
Following the announcement in the Spring Budget, Innovate UK will be inviting industry-led proposals within the first round of the new Industrial Strategy Challenge Fund.
The “Challenge Areas” are likely to include:
• Antimicrobial resistance
Utilising new technologies and treatments to reduce AMR by 50% by 2025/30
• Innovation in health & disease detection using diagnostic, preventative & sensor technologies
Developing diagnostics and sensors that enable anticipation and prevention of disease in the healthy, elderly and chronically ill. To precisely diagnose and treat disease in the ill, to improve compliance with medication, and to enable independent living.
The NIHR DEC Newcastle and it partners would be very pleased to discuss working with firms or consortia planning to lead ISCF bids.
EPSRC Global Challenges Research Fund: Diagnostics, prosthetics and orthotics to tackle health challenges in developing countries
The call is seeking development of innovative healthcare technologies, to tackle the challenges faced by developing countries in particular low cost, rapid, point of care imaging and diagnostic technologies.
EOI to be submitted by 20 April
Closing date 25 May. See here for more details
UK – Philippines: Joint Health Research Initiative Call for concept proposals
This initiative will provide funding for high quality 3-year collaborative research projects focusing on Communicable and Non-Communicable Diseases of relevance to the Philippines. See here for more details, closing date 16:00 BST Thursday 11th May 2017
Adopting MedTech for Patient Benefit 2017
International Centre for Life, Newcastle - 3rd March 2017
Presentations from the event are available here
Innovation and Technology Tariff (ITT)
The ITT, operational from April 2017,will remove the need for multiple price negotiations between providers and suppliers, and instead guarantee automatic reimbursement when an approved innovation is used, see AHSN website for further info.
6th UK Diagnostic Forum, Oxford, 16-17 May 2017
The NIHR Diagnostics Forum is a meeting of industry, academia and healthcare professionals developing ways to facilitate the utilisation and adoption of innovative tests through good quality evidence.
Further detail can be found at NIHR DEC Oxford website